Animal-derived Immune Globulin Products Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

1 RESEARCH SCOPE

1.1 Research Product Definition

1.2 Research Segmentation

1.2.1 Product Type

1.2.2 Main product Type of Major Players

1.3 Demand Overview

1.4 Research Methodology

2 GLOBAL ANIMAL-DERIVED IMMUNE GLOBULIN PRODUCTS INDUSTRY

2.1 Summary about Animal-derived Immune Globulin Products Industry

2.2 Animal-derived Immune Globulin Products Market Trends

2.2.1 Animal-derived Immune Globulin Products Production & Consumption Trends

2.2.2 Animal-derived Immune Globulin Products Demand Structure Trends

2.3 Animal-derived Immune Globulin Products Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020

3.2 Market Development under the Impact of COVID-19

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunity

3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)

4.1.1 North America (U.S., Canada and Mexico)

4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)

4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)

4.1.4 South America (Brazil,, Argentina, Rest of Latin America)

4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)

4.2 Product Type Segmentation (2017 to 2021f)

4.2.1 IVIg Liquid

4.2.2 IVIg Powder

4.3 Consumption Segmentation (2017 to 2021f)

4.3.1 Immunodeficiency

4.3.2 Autoimmune Disease

4.3.3 Acute Infection

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)

5.1.1 U.S.

5.1.2 Canada

5.1.3 Mexico

5.2 Product Type Segmentation (2017 to 2021f)

5.2.1 IVIg Liquid

5.2.2 IVIg Powder

5.3 Consumption Segmentation (2017 to 2021f)

5.3.1 Immunodeficiency

5.3.2 Autoimmune Disease

5.3.3 Acute Infection

5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)

6.1.1 Germany

6.1.2 UK

6.1.3 France

6.1.4 Italy

6.1.5 Rest of Europe

6.2 Product Type Segmentation (2017 to 2021f)

6.2.1 IVIg Liquid

6.2.2 IVIg Powder

6.3 Consumption Segmentation (2017 to 2021f)

6.3.1 Immunodeficiency

6.3.2 Autoimmune Disease

6.3.3 Acute Infection

6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)

7.1.1 China

7.1.2 India

7.1.3 Japan

7.1.4 South Korea

7.1.5 Southeast Asia

7.1.6 Australia

7.1.7 Rest of Asia Pacific

7.2 Product Type Segmentation (2017 to 2021f)

7.2.1 IVIg Liquid

7.2.2 IVIg Powder

7.3 Consumption Segmentation (2017 to 2021f)

7.3.1 Immunodeficiency

7.3.2 Autoimmune Disease

7.3.3 Acute Infection

7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)

8.1.1 Brazil

8.1.2 Argentina

8.1.3 Rest of Latin America

8.2 Product Type Segmentation (2017 to 2021f)

8.2.1 IVIg Liquid

8.2.2 IVIg Powder

8.3 Consumption Segmentation (2017 to 2021f)

8.3.1 Immunodeficiency

8.3.2 Autoimmune Disease

8.3.3 Acute Infection

8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)

9.1.1 GCC

9.1.2 North Africa

9.1.3 South Africa

9.1.4 Rest of Middle East and Africa

9.2 Product Type Segmentation (2017 to 2021f)

9.2.1 IVIg Liquid

9.2.2 IVIg Powder

9.3 Consumption Segmentation (2017 to 2021f)

9.3.1 Immunodeficiency

9.3.2 Autoimmune Disease

9.3.3 Acute Infection

9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players

10.1.1 Pfizer

10.1.2 Rare Disease Therapeutics

10.1.3 Instituto Bioclon

10.1.4 Merck & Co

10.1.5 Sanofi

10.1.6 Protherics

10.1.7 Genzyme Corporation

10.2 Animal-derived Immune Globulin Products Sales Date of Major Players (2017-2020e)

10.2.1 Pfizer

10.2.2 Rare Disease Therapeutics

10.2.3 Instituto Bioclon

10.2.4 Merck & Co

10.2.5 Sanofi

10.2.6 Protherics

10.2.7 Genzyme Corporation

10.3 Market Distribution of Major Players

10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region

11.2 Forecast by Demand

11.3 Environment Forecast

11.3.1 Impact of COVID-19

11.3.2 Geopolitics Overview

11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

Table Animal-derived Immune Globulin Products Product Type Overview

Table Animal-derived Immune Globulin Products Product Type Market Share List

Table Animal-derived Immune Globulin Products Product Type of Major Players

Table Brief Introduction of Pfizer

Table Brief Introduction of Rare Disease Therapeutics

Table Brief Introduction of Instituto Bioclon

Table Brief Introduction of Merck & Co

Table Brief Introduction of Sanofi

Table Brief Introduction of Protherics

Table Brief Introduction of Genzyme Corporation

Table Products & Services of Pfizer

Table Products & Services of Rare Disease Therapeutics

Table Products & Services of Instituto Bioclon

Table Products & Services of Merck & Co

Table Products & Services of Sanofi

Table Products & Services of Protherics

Table Products & Services of Genzyme Corporation

Table Market Distribution of Major Players

Table Global Major Players Sales Revenue (Million USD) 2017-2020e

Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

Table Global Animal-derived Immune Globulin Products Market Forecast (Million USD) by Region 2021f-2026f

Table Global Animal-derived Immune Globulin Products Market Forecast (Million USD) Share by Region 2021f-2026f

Table Global Animal-derived Immune Globulin Products Market Forecast (Million USD) by Demand 2021f-2026f

Table Global Animal-derived Immune Globulin Products Market Forecast (Million USD) Share by Demand 2021f-2026f